Abstract
After a marked decline in the number of syphilis cases in the context of AIDS prevention campaigns, a significant increase has been observed in states of the former Soviet Union since 1994. In recent years, outbreaks have also been reported in the US, Canada, and several European countries. The current epidemic in the US and in different parts of Europe has largely involved men who have sex with men, many of whom are infected with HIV. Since a misdiagnosis of syphilis can have serious consequences for the patient and also for pregnancies and newborns, clinicians should be aware of the many manifestations of syphilis and difficulties in the diagnosis and management of the disease. Younger clinicians in particular are no longer familiar with the diverse clinical symptoms and the complex diagnostics of syphilis. Patients co-infected with HIV may present with atypical clinical manifestations and laboratory test results. Furthermore, through its association with an increased risk of HIV infection, syphilis has acquired a new potential for morbidity and mortality, and the diagnosis of syphilis should be routinely considered in patients with uveitis, sudden deafness, aortic thoracic aneurysm, or pregnancy.
Only a minority of syphilis infections are detected in the primary stage. This may be because of atypical locations and, occasionally, atypical morphology of the lesions; however, it may also be because of the difficulty of detecting the pathogen. In the secondary stage, which is clinically extremely diverse, the diagnosis is confirmed serologically. There is a need for increased awareness of the symptoms and signs of acute infections, together with a willingness to consider the diagnosis of syphilis in patients with vague symptoms. An increasing number of diagnostic tests (both specific and nonspecific) are now available. However, in the absence of clinical symptoms or in cases with a low titer or inconsistent test results, diagnosis of syphilis can be difficult or even impossible. Treatment and follow-up should follow current guidelines designed for the involved area.
In this article, the cutaneous manifestations of syphilis and their diagnostic and therapeutic management are described in detail.
Similar content being viewed by others
References
Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003; 290: 1510–4
Hook III EW, Marra CM. Acquired syphilis in adults. N Engl J Med. 1992; 326: 1060–9
Garnett GP, Aral SO, Hoyle DV, et al. The natural history of syphilis: implications for the transmission dynamics and control of infection. Sex Transm Dis. 1997; 24: 185–200
Sanchez MR. Syphilis. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 2003: 2163–88
van Duynhoven YT. The epidemiology of Neisseria gonorrhoeae in Europe. Microbes Infect. 1999; 1: 455–64
US Centers for Disease Control and Prevention. Summary of notifiable diseases: United States, 2003. MMWR Moth Mortal Wkly Rep. 2005; 52: 1–85
Chesson HW, Dee TS, Aral SO. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex Transm Dis. 2003; 30: 419–24
Tichonova L, Borisenko K, Ward H, et al. Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control. Lancet. 1997; 350: 210–3
US Centers for Disease Control and Prevention. Outbreak of syphilis among men who have sex with men: Southern California, 2000. MMWR Moth Mortal Wkly Rep. 2001; 50: 117–20
Nicoll A, Hamers FF. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe?. BMJ. 2002; 324: 1324–7
Peterman TA, Heffelfinger JD, Swint EB, et al. The changing epidemiology of syphilis. Sex Transm Dis. 2005; 32: S4–10
Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect. 2004; 80: 255–63
Tikhonova L, Salakhov E, Southwick K, et al. Congenital syphilis in the Russian Federation: magnitude, determinants, and consequences. Sex Transm Infect. 2003; 79: 106–10
Masher DM. Early syphilis. In: Holmes KK, Sparling PF, Mardh P, et al., editors. Sexually transmitted diseases. New York: McGraw-Hill, 1999: 479–85
DiCarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis. 1997; 25: 292–8
Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 2004; 4: 456–66
Lautenschlager S. Sexually transmitted infections in Switzerland: return of the classics. Dermatology. 2005; 210: 134–42
Lacey HB, Higgins SP, Graham D. An outbreak of early syphilis: cases from North Manchester General Hospital. Sex Transm Infect. 2001; 77: 311–3
Dourmishev LA, Dourmishev AL. Syphilis: uncommon presentations in adults. Clin Dermatol. 2005; 23: 555–64
Hutchinson CM, Hook III EW, Shepherd M, et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med. 1994; 121: 94–100
Chapel TA, Prasad P, Chapel J, et al. Extragenital syphilitic chancres. J Am Acad Dermatol. 1985; 13: 582–4
Schöfer H. Syphilis, Klinik der Treponema-pallidum-Infektion. Hautarzt. 2004; 55: 112–9
Haustein UF, Pfeil B, Zschiesche A. Analyse der von 1983-1991 an der Universitäts-Hautklinik Leipzig beobachteten Syphilisfdlle. Hautarzt. 1993; 44: 23–9
Alam F, Argiriadou AS, Hodgson TA, et al. Primary syphilis remains a cause of oral ulceration. Br Dent J. 2000; 189: 352–4
Ashton M, Sopwith W, Clark P, et al. An outbreak no longer: factors contributing to the return of syphilis in Greater Manchester. Sex Transm Infect. 2003; 79: 291–3
Arunkumar S, Prasad S, Loganathan B, et al. Extragenital chancre of the tongue. Int J STD AIDS. 1997; 8: 655–6
Hourihan M, Wheeler H, Houghton R, et al. Lessons from the syphilis outbreak in homosexual men in east London. Sex Transm Infect. 2004; 80: 509–11
Edwards S, Carne C. Oral sex and transmission of non-viral STIs. Sex Transm Infect. 1998; 74: 95–100
Edwards S, Carne C. Oral sex and the transmission of viral STIs. Sex Transm Infect. 1998; 74: 6–10
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999; 75: 3–17
Doherty L, Fenton KA, Jones J, et al. Syphilis: old problem, new strategy. BMJ. 2002; 325: 153–6
US Centers for Disease Control and Prevention. Transmission of primary and secondary syphilis by oral sex: Chicago, Illinois, 1998-2002. MMWR Moth Mortal Wkly Rep. 2004; 53: 966–8
Bonci A, Di Lemia V, Lo Scocco G, et al. A patient with primary syphilis of the finger. Acta Derm Venereol. 2001; 81: 382–3
de Koning GA, Blog FB, Stolz E. A patient with primary syphilis of the hand. Br J Vener Dis. 1977; 53: 386–8
Weber B. Fin Fall von syphilitischem Primäraffekt am Lid. Klin Monatsbl Augenheilkd. 1982; 180: 565–6
Donofrio P. Unusual location of syphilitic chancre: case report. Genitourin Med. 1986; 62: 59–60
Lautenschlager S, Schwarzkopf S, Borelli S. Presternal indurated ulceration: primary syphilis. Dermatology. 2006; 212: 200–2
Allison SD. Extragenital syphilitic chancres. J Am Acad Dermatol. 1986; 14: 1094–5
Fournier A. Treatment and prophylaxis of syphilis. London: Rebman Limited, 1906
Hutchinson CM, Hook III EW. Syphilis in adults. Med Clin North Am. 1990; 74: 1389–416
Rompalo AM, Joesoef MR, O’Donnell JA, et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis. 2001; 28: 158–65
Martin DH, Mroczkowski TF. Dermatologic manifestations of sexually transmitted diseases other than HIV. Infect Dis Clin North Am. 1994; 8: 533–82
Friedli A, Chavaz P, Harms M. Alopecia syphilitica: report of two cases in Geneva. Dermatology. 2001; 202: 376–7
Wenhai L, Jianzhong Z, Cao Y. Detection of Treponema pallidum in skin lesions of secondary syphilis and characterization of the inflammatory infiltrate. Dermatology. 2004; 208: 94–7
Division of STD Prevention, US National Center for HIV, STD, and TB Prevention. Recommendations for public health surveillance of syphilis in the United States [online]. Atlanta (GA): Centers for Disease Control and Prevention, 2003. Available from URL: http://www.ede.gov/std/SyphSurvReco.pdf [Accessed 2006 Sep 13]
World Health Organization. Guidelines for the management of sexually transmitted infections [online]. Geneva: WHO, 2003. Available from URL: http://www.who.int/hiv/pub/sti/en/STIGuidelines2003.pdf [Accessed 2006 Aug 10]
Zeltser R, Kurban AK. Syphilis. Clin Dermatol. 2004; 22: 461–8
Sale RR, Deshpande SG, Dharmadhikari NJ, et al. Late cutaneous syphilis. Cutis. 1997; 59: 135–7
Löwhagen GB. Syphilis: test procedures and therapeutic strategies. Semin Dermalot. 1990; 9: 152–9
Cummings MC, Lukehart SA, Marra C, et al. Comparison of methods for the detection of Treponema pallidum in lesions of early syphilis. Sex Transm Dis. 1996; 23: 366–9
Palmer HM, Higgins SP, Herring AJ, et al. Use of PCR in the diagnosis of early syphilis in the United Kingdom. Sex Transm Infect. 2003; 79: 479–83
Wheeler HL, Agarwal S, Gob BT. Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis. Sex Transm Infect. 2004; 80: 411–4
Rogstad KE, Simms I, Fenton KA, et al. Screening, diagnosis and management of early syphilis in genitourinary medicine clinics in the UK. Int J STD AIDS. 2005; 16: 348–52
Liu H, Rodes B, Chen CY, et al. New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase I gene. J Clin Microbiol. 2001; 39: 1941–6
Young H. Syphilis: serology. Dermatol Clin. 1998; 16: 691–8
Gob BT, Voorst Vader PC. European guideline for the management of syphilis. Int J STD AIDS. 2001; 12 Suppl. 3: 14–26
Schöfer H, Brockmeyer NH, Hagedorn HJ, et al. Syphilis: Leitfnie der DSTDG zur Diagnostik and Therapie. Hautarzt. 2005; 56: 1084–100
Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997 Jul 31; 337 (5): 307–14
Young H. Guidelines for serological testing for syphilis. Sex Transm Infect. 2000; 76: 403–5
US Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep. 2006; 55 (No. RR-11): 1–100
Nandwani R, Evans DT. Are you sure it’s syphilis? A review of false positive serology. Int J STD AIDS. 1995; 6: 241–8
Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995; 8: 1–21
Kuznetsov AV, Burgdorf WH, Prinz JC. Latent syphilis confirmed by polymerase chain reaction in 2 HIV-positive patients with inconclusive serologic test results. Arch Dermatol. 2005; 141: 1169–70
Smith G, Holman RP. The prozone phenomenon with syphilis and HIV-1 co-infection. South Med. 2004; 97: 379–82
Taniguchi S, Osato K, Hamada T. The prozone phenomenon in secondary syphilis. Acta Derm Venereol. 1995; 75: 153–4
Egglestone SI, Turner AJ. Serological diagnosis of syphilis. PHLS Syphilis Serology Working Group. Commun Dis Public Health. 2000; 3: 158–62
Koff AB, Rosen T. Nonvenereal treponematoses: yaws, endemic syphilis, and pinta. J Am Acad Dermatol. 1993; 29: 519–35
Marangoni A, Sambri V, Cavrini F, et al. Treponema denticola infection is not a cause of false positive Treponema pallidum serology. New Microbiol. 2005; 28: 215–21
Erbelding EJ, Vlahov D, Nelson KE, et al. Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis. 1997; 176: 1397–400
Schmidt BL. Evaluation of a new particle gel immunoassay for determination of antibodies against Treponema pallidum. J Clin Microbiol. 2004; 42: 2833–5
Schmidt BL, Edjlalipour M, Luger A. Comparative evaluation of nine different enzyme-linked immunosorbent assays for determination of antibodies against Treponema pallidum in patients with primary syphilis. J Clin Microbiol. 2000 Mar; 38 (3): 1279–82
Schöfer H. Diagnostik and Behandlung der Syphilis: Leitlinien der DSTDG. MedReport. 2004; 28: 12
Backhouse JL, Nesteroff SI. Treponema pallidum western blot: comparison with the FTA-ABS test as a confirmatory test for syphilis. Diagn Microbiol Inf Dis. 2001 Jan; 39 (1): 9–14
Goldmeier D, Hay P. A review and update on adult syphilis, with particular reference to its treatment. Int J STD AIDS. 1993; 4: 70–82
Hicks CB, Benson PM, Lupton GP, et al. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma: a diagnostic dilemma. Ann Intern Med. 1987; 107: 492–5
Augenbraun M, Rolfs R, Johnson R, et al. Treponemal specific tests for the serodiagnosis of syphilis. Syphilis and HIV Study Group. Sex Transm Dis. 1998; 25: 549–52
Haslett P, Laverty M. The prozone phenomenon in syphilis associated with HIV infection. Arch Intern Med. 1994; 154: 1643–4
Malone JL, Wallace MR, Hendrick BB, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med. 1995; 99: 55–63
Javier M, Chastang C, Spindler E, et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology. 1999; 198: 362–9
Rompalo AM, Cannon RO, Quinn TC, et al. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis. 1992; 165: 1124–6
National guideline for the management of early syphilis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect. 1999 Aug; 75 Suppl. 1: S29–33
National guideline for the management of late syphilis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect. 1999 Aug; 75 Suppl. 1: S34–7
Parkes R, Renton A, Meheus A, et al. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS. 2004; 15: 73–88
Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005; 353: 1236–44
Lukehart SA, Godomes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004; 351: 154–8
Mitchell SJ, Engelman J, Kent CK, et al. Azithromycin-resistant syphilis infection: San Francisco (CA), 2000-2004. Clin Infect Dis. 2006; 42: 337–45
Acknowledgments
The author has received grants to conduct epidemiologic studies of sexually transmitted infection in Switzerland but has no conflicts of interest that are directly relevant to the contents of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lautenschlager, S. Cutaneous Manifestations of Syphilis. Am J Clin Dermatol 7, 291–304 (2006). https://doi.org/10.2165/00128071-200607050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200607050-00003